North Central London
Joint Formulary
8 Malignant disease and immunosuppression

The formulary for systemic anti-cancer treatments should be viewed alongside the 'National Cancer Drugs Fund list'

08-01-05 Vismodegib


Provider notes

  • NMUH:
    • To be prescribed by the Oncology Team ONLY if CDF funded
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
Link  NICE TA489 (not recommended): Vismodegib for treating basal cell carcinoma

Restricted Drug GP - Red View adult BNF  View SPC online  View childrens BNF  HCD  CDF